Hidehiro Kakizaki
Asahikawa Medical University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Hidehiro Kakizaki.
BJUI | 2013
Seiji Matsumoto; Kazumi Hashizume; Naoki Wada; Jyunichi Hori; Gaku Tamaki; Masafumi Kita; Tatsuya Iwata; Hidehiro Kakizaki
There is known to be an association between overactive bladder (OAB) and irritable bowel syndrome (IBS). The study investigates the association between OAB and IBS using an internet‐based survey in Japan. It is the first to investigate the prevalence and severity of OAB in the general population using the OAB symptom score questionnaire.
International Journal of Impotence Research | 2014
Seiji Matsumoto; M Matsuda; M Takekawa; M Okada; Kazumi Hashizume; Naoki Wada; Hori J; G Tamaki; Masafumi Kita; Tatsuya Iwata; Hidehiro Kakizaki
To examine the relationship between chronic periodontal disease (CPD) and ED, the interview sheet including the CPD self-checklist (CPD score) and the five-item version of the International Index of Erectile Function (IIEF-5) was distributed to 300 adult men who received a comprehensive dental examination. Statistical analyses were performed by the Spearmans rank correlation coefficient and other methods. Statistical significance was accepted at the level of P<0.05. The interview sheets were collected from 88 men (response rate 29.3%, 50.9±16.6 years old). There was a statistically significant correlation between the CPD score and the presence of ED (P=0.0415). The results in the present study suggest that ED is related to the damage caused by endothelial dysfunction and the systematic inflammatory changes associated with CPD. The present study also suggests that dental health is important as a preventive medicine for ED.
Urology | 2013
Seiji Matsumoto; Tomohiro Ueda; Hidehiro Kakizaki
OBJECTIVEnTo investigate the efficacy of hydrogen-rich water for the treatment of patients with interstitial cystitis/painful bladder syndrome (IC/PBS).nnnMETHODSnWe conducted a prospective, randomized, double-blind, placebo-controlled clinical trial of hydrogen-rich water in patients with IC/PBS. Inclusion criteria were stable symptoms of IC/PBS for ≥ 12 weeks after bladder hydrodistension, Interstitial Cystitis Symptom Index score of ≥ 7 and bladder pain (question 4 on Interstitial Cystitis Symptom Index) of ≥ 4. They were randomized by a 2:1 ratio to receive hydrogen-rich water or placebo water for 8 weeks. The symptoms were assessed using the Interstitial Cystitis Symptom Index, Interstitial Cystitis Problem Index, Parsons Pelvic Pain and Urgency/Frequency Patient Symptom Scale, visual analog scale bladder pain scores, and a standard 3-day voiding diary. The primary outcome was improvement of patient-reported symptoms evaluated after treatment.nnnRESULTSnA total of 30 participants (29 women and 1 man, age 64.0 ± 14.8 years) were enrolled in the present study, and 2 patients (both women) were withdrawn from the study. The score of bladder pain was significantly reduced in both groups. However, the effect of hydrogen-rich water on symptoms was not significantly different from that of placebo, although supplementation with hydrogen-rich water was extremely effective in improving the bladder pain score in 11% of the patients.nnnCONCLUSIONnThe results of the present study do not support the use of supplementation with hydrogen-rich water for treating patients with IC/PBS.
Neurourology and Urodynamics | 2013
Naoki Wada; Masafumi Kita; Kazumi Hashizume; Seiji Matsumoto; Hidehiro Kakizaki
We prospectively investigated the effect of dutasteride on clinical and urodynamic parameters in patients with benign prostatic enlargement (BPE).
International Journal of Urology | 2013
Naoki Wada; Seiji Matsumoto; Masafumi Kita; Masaki Watanabe; Kazumi Hashizume; Hidehiro Kakizaki
Objectives:u2003 To investigate the effect of intrathecal administration of E‐series prostaglandinu20031 antagonist in cyclophosphamide‐induced murine cystitis.
International Journal of Urology | 2014
Naoki Wada; Atsushi Numata; Kyokushin Hou; Masaki Watanabe; Masafumi Kita; Seiji Matsumoto; Hiroaki Osanai; Makoto Fujisawa; Hidehiro Kakizaki
To evaluate the clinical efficacy of transurethral resection of the prostate on nocturia and sleep disorders in patients with lower urinary tract symptoms suggestive of benign prostatic obstruction.
Neurourology and Urodynamics | 2013
Yuko Kawai; Michiko Oka; Junko Kyotani; Tatsuya Oyama; Seiji Matsumoto; Hidehiro Kakizaki
Ischemia–reperfusion injury is an important factor in the development of lower urinary tract symptoms (LUTS) that is partly mediated by the generation of free radicals. We investigate the effect of the phytotherapeutic agent Eviprostat, a treatment for benign prostatic hyperplasia (BPH) that has antioxidant and anti‐inflammatory activity, on urinary bladder blood flow (BBF), and function in a rat model of bladder overdistension and emptying (OE).
International Journal of Urology | 2013
Satoshi Yamaguchi; Hiroaki Osanai; Atsushi Numata; Masaki Watanabe; Hidehiro Kakizaki
To examine the efficacy of dose increase therapy in patients with lower urinary tract symptoms associated with benign prostatic hyperplasia who responded poorly to 50u2009mg/day of naftopidil.
International Journal of Urology | 2014
Naoki Wada; Seiji Matsumoto; Masafumi Kita; Kazumi Hashizume; Hidehiro Kakizaki
To examine urinary nerve growth factor before and after dutasteride treatment, and to analyze correlations between clinical parameters and change of urinary nerve growth factor in patients with benign prostatic enlargement.
International Urology and Nephrology | 2014
Tadasu Motoya; Seiji Matsumoto; Satoshi Yamaguchi; Naoki Wada; Atsushi Numata; Hiroaki Osanai; Hidehiro Kakizaki
ObjectivesTo investigate the impact of abdominal aortic calcification and visceral fat area (VFA) on lower urinary tract symptoms (LUTS) and clinical parameters in patients with benign prostatic hyperplasia (BPH).MethodsWe retrospectively studied 250 patients with LUTS associated with BPH. Each participant was examined with routine examination including measurement of various data; (1) voided volume (VV), maximum urinary flow rate on free uroflowmetry, (2) postvoid residual urine volume and prostate volume using transabdominal ultrasound, (3) International Prostate Symptom Score (IPSS) and Overactive Bladder Symptom Score (OABSS), and (4) aortic calcification index (ACI) and VFA were measured by abdominal CT.ResultsMean age of the patients was 72.4xa0±xa09.6xa0years. ACI significantly correlated with VV (Pxa0=xa00.0392) and tended to correlate with maximum urinary flow rate, while ACI did not correlate with subjective symptoms. VFA significantly correlated with nocturia score of IPSS (Pxa0=xa00.0177) and frequency score of OABSS (Pxa0=xa00.0166) and tended to correlate with urgency score of IPSS and maximum urinary flow rate.ConclusionsAortic calcification index (ACI) correlated with only objective parameters, while VFA correlated with only storage symptoms. This study suggested that abdominal aortic calcification and VFA have certain influence on LUTS and clinical parameters in patients with BPH.